Related Experiment Video
Updated: May 24, 2026
11:07
Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
Published on: November 24, 2021
Comparative Study of Rotigotine Release and Permeation from the Neupro® Transdermal Patch: An In Vitro-In Vivo
Thamara de Carvalho Mendes1, Hellen Regina Oliveira de Almeida1, Lucio Mendes Cabral2
1Laboratory for Drug and Medicine Quality Control (LabCQ), Department of Drugs and Pharmaceutics, Faculty of Pharmacy, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
AAPS Pharmscitech
|May 22, 2026
Summary
This study characterized rotigotine (RTG) transdermal delivery using dissolution and diffusion tests. In vitro data strongly correlated with in vivo absorption, validating models for quality control and formulation development.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Biopharmaceutics
Background:
- Rotigotine (RTG) is a crucial non-ergolinic dopaminergic agonist for Parkinson's and Willis-Ekbom diseases.
- RTG is exclusively delivered via the Neupro® transdermal patch, presenting formulation and delivery challenges.
Purpose of the Study:
- To characterize the transdermal delivery profile of rotigotine (RTG).
- To establish an in vitro-in vivo correlation (IVIVC) for the RTG transdermal system.
- To validate in vitro methods for quality control and formulation optimization.
Main Methods:
- Utilized USP dissolution testing (Apparatus 5 and 6) and Franz diffusion cells with synthetic membranes and pig ear skin.
- Employed HPLC-DAD for RTG quantification and Wagner-Nelson deconvolution for IVIVC establishment.
- Investigated varying agitation speeds and media compositions for release testing.
Main Results:
- USP Apparatus 5 at 75 rpm in pH 6.0 buffer demonstrated the most discriminative release.
- In vitro permeation through pig ear skin showed a strong correlation with in vivo data (R² = 0.9819).
- Synthetic membranes facilitated complete release but did not mimic skin barrier function.
Conclusions:
- Developed in vitro methods effectively differentiate transdermal patches, suitable for quality control.
- The study highlights the predictive power of in vitro models for in vivo performance of RTG transdermal systems.
- Established IVIVC supports formulation optimization and guides regulatory bioequivalence studies.
Related Concept Videos
01:20Drug Product Performance: In Vitro–In Vivo Correlation
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...
01:09Methods for Studying Drug Absorption: In situ
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
01:16Methods for Studying Drug Absorption: In vitro
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:09In Vitro Drug Dissolution: Compendial Testing Models II
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...